The effect of inhaled β2-agonists on clinical outcomes in chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

The effect of inhaled β2-agonists on clinical outcomes in chronic obstructive pulmonary disease

Published:2002-12 Issue:6 Volume:110 Page:S298-S303
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Mahler Donald A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease;Nocturnal Oxygen Therapy Trial Group;Ann Intern Med,1980

2. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis emphysema;Medical Research Council Working Party;Lancet,1981

3. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study;Anthonisen;JAMA,1994

4. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue to smoke;Pauwels;N Engl J Med,1999

5. Randomised, double-blind, placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial;Burge;BMJ,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of salbutamol in pure form and pharmaceutical formulations using spectrophotometry and green nonionic surfactant of cloud point extraction;Journal of Physics: Conference Series;2021-03-01

2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002–2013;Respiratory Medicine;2017-09

3. Effects of individual and neighborhood socioeconomic status on the risk of all-cause mortality in chronic obstructive pulmonary disease: A nationwide population-based cohort study, 2002–2013;Respiratory Medicine;2016-05

4. New developments in the management of COPD: clinical utility of indacaterol 75 µg;International Journal of Chronic Obstructive Pulmonary Disease;2013-12

5. Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease;Expert Opinion on Pharmacotherapy;2012-04-04